Pfizer’s $43B deal for Seagen gets European Union review
Jeenah Moon/Getty Images News Pfizer's (PFE) planned $43 billion acquisition of oncology drugmaker Seagen (NASDAQ:SGEN) will see a European Union antitrust review after the companies notified the antitrust regulator about the…
